We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

73 hedge funds and large institutions have $230M invested in Tempest Therapeutics in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less capital invested

Capital invested by funds: $243M → $230M (-$12.7M)

6% less funds holding

Funds holding: 78 → 73 (-5)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

88% less call options, than puts

Call options by funds: $80K | Put options by funds: $640K

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
23
Closed
14
Calls
$80K
Puts
$640K
Net Calls
-$560K
Net Calls Change
+$4.44M

Top Buyers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
+$6.07M
2
Jennison Associates
Jennison Associates
New York
+$4.33M
3
PCM
Portolan Capital Management
Massachusetts
+$2.83M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$423K
5
Millennium Management
Millennium Management
New York
+$296K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$4.15M
2
JHIU
Janus Henderson Investors US
Colorado
-$2.58M
3
Goldman Sachs
Goldman Sachs
New York
-$2.35M
4
ACH
ArrowMark Colorado Holdings
Colorado
-$1.75M
5
Fidelity International
Fidelity International
Bermuda
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFS
76
MSI Financial Services
Massachusetts
$6K – – –
PFO
77
Pathstone Family Office
New Jersey
$5K – – –
Zurich Cantonal Bank
78
Zurich Cantonal Bank
Switzerland
$3K – – –
Barclays
79
Barclays
United Kingdom
$2K -$21.1K -1 Closed
Geode Capital Management
80
Geode Capital Management
Massachusetts
$1.56K +$106K +5 +10%
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
$1.46K -$42.3K -2 Closed
KF
82
Krilogy Financial
Missouri
$1K – – –
PNC Financial Services Group
83
PNC Financial Services Group
Pennsylvania
$1K – – –
EC
84
EcoR1 Capital
California
– -$4.15M -145 Closed
Fidelity International
85
Fidelity International
Bermuda
– -$1.62M -57 Closed
Renaissance Technologies
86
Renaissance Technologies
New York
– -$952K -33 Closed
CG
87
Cutler Group
California
– -$634K -30 Closed
LCM
88
Landscape Capital Management
New Jersey
– -$647K -23 Closed
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
– -$162K -6 Closed
Squarepoint
90
Squarepoint
New York
– -$142K -5 Closed
EA
91
Emerald Advisers
Pennsylvania
– -$109K -4 Closed
Balyasny Asset Management
92
Balyasny Asset Management
Illinois
– -$98K -3 Closed
Group One Trading
93
Group One Trading
Illinois
– -$42.3K -2 Closed
1 2 3
4

TPST Hedge Fund Activity: Q1 2016 in Review

73 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2016, worth a combined $230M — down 5.2% from $243M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TPST and 10 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 19 added.

The largest buyer was GMT Capital, opening a new position worth an estimated $6.07M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $4.15M sold.

  • 73 institutional investors held Tempest Therapeutics (TPST) as of Q1 2016, down from 78 in Q4 2015.
  • Funds reported $230M of Tempest Therapeutics stock for Q1 2016, down 5.2% quarter-over-quarter.
  • 10 funds opened new Tempest Therapeutics positions in Q1 2016 and 14 closed out, a net change of -4 holders.
  • The largest Tempest Therapeutics buyer in Q1 2016 was GMT Capital, an estimated $6.07M added.
  • The largest Tempest Therapeutics seller in Q1 2016 was EcoR1 Capital, an estimated $4.15M sold.

Based on aggregated 13F filings for Q1 2016.